UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Datensatz exportieren als...
BibTeX
Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Movement disorders, 2024-08, Vol.39 (8), p.1289-1299
Kluge, Annika
Schaeffer, Eva
Bunk, Josina
Sommerauer, Michael
Röttgen, Sinah
Schulte, Claudia
Roeben, Benjamin
Thaler, Anna‐Katharina
Welzel, Julius
Lucius, Ralph
Heinzel, Sebastian
Xiang, Wei
Eschweiler, Gerhard W.
Maetzler, Walter
Suenkel, Ulrike
Berg, Daniela
2024
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Kluge, Annika
Schaeffer, Eva
Bunk, Josina
Sommerauer, Michael
Röttgen, Sinah
Schulte, Claudia
Roeben, Benjamin
Thaler, Anna‐Katharina
Welzel, Julius
Lucius, Ralph
Heinzel, Sebastian
Xiang, Wei
Eschweiler, Gerhard W.
Maetzler, Walter
Suenkel, Ulrike
Berg, Daniela
Titel
Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Ist Teil von
Movement disorders, 2024-08, Vol.39 (8), p.1289-1299
Ort / Verlag
Hoboken, USA: John Wiley & Sons, Inc
Erscheinungsjahr
2024
Quelle
Wiley Online Library
Beschreibungen/Notizen
Background Identifying individuals with Parkinson's disease (PD) already in the prodromal phase of the disease has become a priority objective for opening a window for early disease‐modifying therapies. Objective The aim was to evaluate a blood‐based α‐synuclein seed amplification assay (α‐syn SAA) as a novel biomarker for diagnosing PD in the prodromal phase. Methods In the TREND study (University of Tuebingen) biennial blood samples of n = 1201 individuals with/without increased risk for PD were taken prospectively over 4 to 10 years. We retrospectively analyzed blood samples of 12 participants later diagnosed with PD during the study to detect and amplify pathological α‐syn conformers derived from neuronal extracellular vesicles using (1) immunoblot analyses with an antibody against these conformers and (2) an α‐syn‐SAA. Additionally, blood samples of n = 13 healthy individuals from the TREND cohort and n = 20 individuals with isolated rapid eye movement sleep behavior disorder (iRBD) from the University Hospital Cologne were analyzed. Results All individuals with PD showed positive immunoblots and a positive α‐syn SAA at the time of diagnosis. Moreover, all PD patients showed a positive α‐syn SAA 1 to 10 years before clinical diagnosis. In the iRBD cohort, 30% showed a positive α‐syn SAA. All healthy controls had a negative SAA. Conclusions We here demonstrate the possibility to detect and amplify pathological α‐syn conformers in peripheral blood up to 10 years before the clinical diagnosis of PD in individuals with and without iRBD. The findings of this study indicate that this blood‐based α‐syn SAA assay has the potential to serve as a diagnostic biomarker for prodromal PD. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Sprache
Englisch
Identifikatoren
ISSN: 0885-3185, 1531-8257
eISSN: 1531-8257
DOI: 10.1002/mds.29766
Titel-ID: cdi_proquest_miscellaneous_3045119011
Format
–
Schlagworte
biomarker
,
Biomarkers
,
Diagnosis
,
Movement disorders
,
Neurodegenerative diseases
,
neuron‐derived extracellular vesicles
,
Parkinson's disease
,
Peripheral blood
,
REM sleep
,
seed amplification assay
,
Sleep disorders
,
Synuclein
,
α‐synuclein
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX